BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 10494333)

  • 1. [Severe withdrawal symptoms with fever upon stopping paroxetine].
    Vergouwen AC; Kuipers T
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1794-5; author reply 1795-6. PubMed ID: 10494332
    [No Abstract]   [Full Text] [Related]  

  • 2. [Severe withdrawal symptoms with fever during paroxetine tapering off].
    Peeters FP; Zandbergen J
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1429-31. PubMed ID: 10422558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Withdrawal symptoms in connection with the use of selective serotonin reuptake inhibitors (SSRI)].
    Gram LF
    Ugeskr Laeger; 1998 Dec; 160(50):7291-3. PubMed ID: 9859737
    [No Abstract]   [Full Text] [Related]  

  • 4. Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
    Miner CM; Brown EB; Gonzales JS; Munir R
    J Clin Psychiatry; 2002 Mar; 63(3):232-40. PubMed ID: 11926723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fluvoxamine and paroxetine on sleep structure in normal subjects: a home-based Nightcap evaluation during drug administration and withdrawal.
    Silvestri R; Pace-Schott EF; Gersh T; Stickgold R; Salzman C; Hobson JA
    J Clin Psychiatry; 2001 Aug; 62(8):642-52. PubMed ID: 11561938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Severe withdrawal symptoms with fever upon stopping paroxetine].
    Bakker A
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1795; author reply 1795-6. PubMed ID: 10494333
    [No Abstract]   [Full Text] [Related]  

  • 7. [Selective serotonin reuptake inhibitors and mammary pathologies].
    Shchepotin IB; Zotov AS; Dobzhenko MN
    Vopr Onkol; 2010; 56(4):393-7. PubMed ID: 20968014
    [No Abstract]   [Full Text] [Related]  

  • 8. Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
    Zajecka J; Tracy KA; Mitchell S
    J Clin Psychiatry; 1997 Jul; 58(7):291-7. PubMed ID: 9269249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New antidepressive agents].
    LaBranche S
    Union Med Can; 1995 Nov; 124(3):8-13. PubMed ID: 8560639
    [No Abstract]   [Full Text] [Related]  

  • 10. [Differential features of SSRIs].
    Cervera S
    Rev Med Univ Navarra; 1997; 41(4):245-57. PubMed ID: 10420965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
    Moore ML; Eichner SF; Jones JR
    Ann Pharmacother; 2004 Sep; 38(9):1515-9. PubMed ID: 15292500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
    Mandrioli R; Mercolini L; Saracino MA; Raggi MA
    Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.